LAUREN LEE: Open Payments
NPI 1073820536 · STATELINE, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 25 payments from 7 companies in 2025. Trend: 2023 $171 · 2024 $257 · 2025 $501
Food & beverage: $492Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $248 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Regeneron Healthcare Solutions, Inc. | 2 | $67 |
| GENZYME CORPORATION | 1 | $31 |
| Lilly USA, LLC | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: DUPIXENT, BOTOX, RINVOQ, SKYRIZI, COSENTYX, TALTZ, ILUMYA, Sotyktu.
Industry payments across NV — which companies pay providers there.
